{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:55:18Z","timestamp":1773406518896,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":782,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7192168"],"award-info":[{"award-number":["7192168"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jtct.2020.11.004","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T01:52:22Z","timestamp":1609379542000},"page":"301-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Advances in Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria"],"prefix":"10.1016","volume":"27","author":[{"given":"Yali","family":"Du","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl_1","key":"10.1016\/j.jtct.2020.11.004_bib0001","article-title":"Epidemiology of PNH and real-world treatment patterns following an incident PNH diagnosis in the US","volume":"134","author":"Jalbert","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.004_bib0002","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","article-title":"Diagnosis and management of paroxysmal nocturnal hemoglobinuria","volume":"106","author":"Parker","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.004_bib0003","unstructured":"International PNH Interest Group (IPIG). International PNH interest group.Available at: https:\/\/www.pnhinterestgroup.org\/. Accessed July 20, 2020."},{"key":"10.1016\/j.jtct.2020.11.004_bib0004","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jtct.2020.11.004_bib0005","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","article-title":"Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival","volume":"117","author":"Kelly","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.004_bib0006","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ajh.24278","article-title":"Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study","volume":"91","author":"Loschi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2020.11.004_bib0007","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/j.bbmt.2018.07.032","article-title":"Eculizumab bridging before bone marrow transplant for marrow failure disorders is safe and does not limit engraftment","volume":"24","author":"DeZern","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.004_bib0008","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood-2018-09-876805","article-title":"Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study","volume":"133","author":"Kulasekararaj","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.004_bib0009","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jtct.2020.11.004_bib0010","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bjh.12661","article-title":"Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anaemia patients treated with combined immunosuppression: results of two-centre prospective study","volume":"164","author":"Kulagin","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2020.11.004_bib0011","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.bbmt.2019.01.033","article-title":"Hematopoietic cell transplantation for paroxysmal nocturnal hemoglobinuria in the age of eculizumab","volume":"25","author":"Cooper","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.004_bib0012","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.3324\/haematol.2012.062828","article-title":"Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria","volume":"97","author":"Peffault de Latour","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2020.11.004_bib0013","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/hon.2367","article-title":"Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: a retrospective single-center study","volume":"35","author":"Kamranzadeh Fumani","year":"2017","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jtct.2020.11.004_bib0014","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","article-title":"Thrombosis in paroxysmal nocturnal hemoglobinuria","volume":"121","author":"Hill","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.004_bib0015","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood-2017-05-782870","article-title":"Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD","volume":"130","author":"Gloude","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.004_bib0016","article-title":"Outcome of allogeneic hematopoietic stem cell transplantation in adult patients with paroxysmal nocturnal hemoglobinuria [e-pub ahead of print]","author":"Nakamura","year":"2020","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2020.11.004_bib0017","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.bbmt.2020.05.024","article-title":"Allogeneic hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: multicenter analysis by the Polish Adult Leukemia Group","volume":"26","author":"Markiewicz","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.004_bib0018","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.3324\/haematol.2017.182360","article-title":"Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers","volume":"103","author":"Vallet","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2020.11.004_bib0019","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bbmt.2019.02.024","article-title":"Excellent outcomes of allogeneic hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria: a single-center study","volume":"25","author":"Liu","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.004_bib0020","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/ejh.12922","article-title":"Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia","volume":"99","author":"Lee","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jtct.2020.11.004_bib0021","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1038\/s41409-019-0751-6","article-title":"Outcomes of haploidentical haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria","volume":"55","author":"Liu","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.004_bib0022","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jiac.2016.05.006","article-title":"An overview of infectious complications after allogeneic hematopoietic stem cell transplantation","volume":"22","author":"Sahin","year":"2016","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jtct.2020.11.004_bib0023","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1473-3099(18)30600-5","article-title":"Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)","volume":"19","author":"Cordonnier","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jtct.2020.11.004_bib0024","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.735.735","article-title":"Should I transplant this patient with paroxysmal nocturnal hemoglobinuria? A cost-effectiveness analysis of eculizumab versus allogeneic stem cell transplant","volume":"124","author":"Marchetti","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2020.11.004_bib0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-2141.1999.01195.x","article-title":"Bone marrow transplants for paroxysmal nocturnal haemoglobinuria","volume":"104","author":"Saso","year":"1999","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtct.2020.11.004_bib0026","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3109\/10428194.2015.1068309","article-title":"Haploidentical hematopoietic stem cell transplant in paroxysmal nocturnal hemoglobinuria","volume":"57","author":"Tian","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2020.11.004_bib0027","first-page":"306","article-title":"[Comparison of haploidentical hematopoietic stem cell transplantation and matched-sibling donor transplantation for the treatment of paroxysmal nocturnal hemoglobinuria]","volume":"40","author":"Liu","year":"2019","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"10.1016\/j.jtct.2020.11.004_bib0028","doi-asserted-by":"crossref","first-page":"983","DOI":"10.3324\/haematol.2009.017269","article-title":"Hematopoietic stem cell transplantation for paroxysmal nocturnal hemoglobinuria: long-term results of a retrospective study on behalf of the Gruppo Italiano Trapianto Midollo Osseo (GITMO)","volume":"95","author":"Santarone","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jtct.2020.11.004_bib0029","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.bbmt.2014.05.012","article-title":"Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria","volume":"20","author":"Pantin","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2020.11.004_bib0030","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/j.bbmt.2019.01.025","article-title":"Post-allogeneic hematopoietic stem cell transplantation eculizumab as prophylaxis against hemolysis and thrombosis for patients with hematologic disorders associated with paroxysmal nocturnal hemoglobinuria clones","volume":"25","author":"Mei","year":"2019","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720300105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636720300105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:00:17Z","timestamp":1763002817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636720300105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2666636720300105"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2020.11.004","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2020.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}